Cargando…

Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice

Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health care costs. Dried blood spot (DBS) microsampling is often use...

Descripción completa

Detalles Bibliográficos
Autores principales: Francke, Marith I., Peeters, Laura E. J., Hesselink, Dennis A., Kloosterboer, Sanne M., Koch, Birgit C. P., Veenhof, Herman, de Winter, Brenda C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467683/
https://www.ncbi.nlm.nih.gov/pubmed/35607881
http://dx.doi.org/10.1097/FTD.0000000000000994
_version_ 1784788241819369472
author Francke, Marith I.
Peeters, Laura E. J.
Hesselink, Dennis A.
Kloosterboer, Sanne M.
Koch, Birgit C. P.
Veenhof, Herman
de Winter, Brenda C. M.
author_facet Francke, Marith I.
Peeters, Laura E. J.
Hesselink, Dennis A.
Kloosterboer, Sanne M.
Koch, Birgit C. P.
Veenhof, Herman
de Winter, Brenda C. M.
author_sort Francke, Marith I.
collection PubMed
description Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health care costs. Dried blood spot (DBS) microsampling is often used for this purpose, wherein capillary blood, obtained by pricking the heel or finger, is used to measure different analytes. Although DBS has several advantages over venous blood sampling, it is not routinely implemented in clinical practice. To facilitate the bench to bedside transition, it is important to be aware of certain challenges that need to be considered and addressed. RESULTS: Here, important considerations regarding the implementation of DBS in clinical practice, the choice of patients, blood sampling, transport, and laboratory analysis are discussed. In addition, we share our experience and provide suggestions on how to deal with these problems in a clinical setting.
format Online
Article
Text
id pubmed-9467683
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Therapeutic Drug Monitoring
record_format MEDLINE/PubMed
spelling pubmed-94676832022-09-13 Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice Francke, Marith I. Peeters, Laura E. J. Hesselink, Dennis A. Kloosterboer, Sanne M. Koch, Birgit C. P. Veenhof, Herman de Winter, Brenda C. M. Ther Drug Monit Short Communication Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health care costs. Dried blood spot (DBS) microsampling is often used for this purpose, wherein capillary blood, obtained by pricking the heel or finger, is used to measure different analytes. Although DBS has several advantages over venous blood sampling, it is not routinely implemented in clinical practice. To facilitate the bench to bedside transition, it is important to be aware of certain challenges that need to be considered and addressed. RESULTS: Here, important considerations regarding the implementation of DBS in clinical practice, the choice of patients, blood sampling, transport, and laboratory analysis are discussed. In addition, we share our experience and provide suggestions on how to deal with these problems in a clinical setting. Therapeutic Drug Monitoring 2022-10 2022-05-23 /pmc/articles/PMC9467683/ /pubmed/35607881 http://dx.doi.org/10.1097/FTD.0000000000000994 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Francke, Marith I.
Peeters, Laura E. J.
Hesselink, Dennis A.
Kloosterboer, Sanne M.
Koch, Birgit C. P.
Veenhof, Herman
de Winter, Brenda C. M.
Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
title Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
title_full Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
title_fullStr Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
title_full_unstemmed Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
title_short Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
title_sort best practices to implement dried blood spot sampling for therapeutic drug monitoring in clinical practice
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467683/
https://www.ncbi.nlm.nih.gov/pubmed/35607881
http://dx.doi.org/10.1097/FTD.0000000000000994
work_keys_str_mv AT franckemarithi bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice
AT peeterslauraej bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice
AT hesselinkdennisa bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice
AT kloosterboersannem bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice
AT kochbirgitcp bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice
AT veenhofherman bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice
AT dewinterbrendacm bestpracticestoimplementdriedbloodspotsamplingfortherapeuticdrugmonitoringinclinicalpractice